Mabion named finalist in four categories at the Life Science Sales & Marketing Awards 2025
Mabion S.A. has been shortlisted in four categories at the Life Science Sales and Marketing Awards (LSSM) 2025, underscoring the company’s growing momentum and marketing excellence across the biopharmaceutical value chain.
A purpose-driven campaign with measurable impact
Mabion’s “Unlocking the Future of Therapeutics” contest reframed what a CDMO-led campaign can achieve by pairing brand storytelling with tangible support for oncology innovation. Launched at BIO International Convention in Boston, the initiative offered €500,000 in biologics development services to help an emerging therapy navigate the funding gap that often stalls progress. The campaign combined a high-profile in-person launch with a targeted digital phase, generating 25 pieces of media coverage, over 240 brand mentions and over 600,000 LinkedIn Ads impressions, and strengthening Mabion’s reputation among European and US biotech decision-makers.
Support Professional of the Year: Life Science frontwoman
As Analytics Development Division Manager, Paulina Toboła has elevated Mabion’s analytical development platform while ensuring rigorous regulatory alignment. Over the last year, her team advanced methods for impurity profiling, similarity assessments, stability studies and reference substance characterization directly improving data reliability and accelerating client timelines.
Externally, Paulina Toboła has represented Mabion at major industry events (including BIO International Convention, Festival of Biologics, and CPHI Frankfurt), contributed to knowledge-sharing through webinars and publications (e.g., Bioprocess Online, Discover Pharma), and helped deepen client partnerships – translating analytical excellence into commercial trust.
One to Watch & Marketing Professional of the Year: a rising leader to follow
Jakub Knurek, Marketing Specialist, has led Mabion’s marketing transformation with a strategy that integrates brand positioning, digital engagement and thought leadership. His work has expanded the company’s international footprint via optimized LinkedIn communications, targeted advertising and editorial contributions to outlets such as Pharma Focus Asia and BiotechStage.
Knurek is also shortlisted for One to Watch, reflecting his accelerated trajectory and outsized impact early in his career. In addition to architecting Mabion’s current marketing strategy, he has been a two-time CPHI Pharma Awards “Future Leader” finalist (2024 and 2025), a discussion panel contributor on the Future Pharma Workforce, and an active mentor through the Polonium Foundation. His thought-leadership portfolio spanning Mabion’s Science Hub, trade media features and widely read LinkedIn explainers has driven strong visibility and engagement for the brand, with top posts reaching tens of thousands of readers.
The recognition reflects the Mabion’s commitment to pairing scientific rigor with communicating real-world value to patients, partners and innovators. From empowering oncology breakthroughs through a €500,000 services contest to elevating analytical standards and modernizing digital outreach, the nominations highlight a year of integrated progress.
Prepared by:
Director of Business Development
Sources and further reading
- Life Science Sales and Marketing Awards. 2025.